Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biomimetic microspheres for 3D mesenchymal stem cell culture and characterization.
Clara-Trujillo S, Marín-Payá JC, Cordón L, Sempere A, Gallego Ferrer G, Gómez Ribelles JL. Clara-Trujillo S, et al. Among authors: cordon l. Colloids Surf B Biointerfaces. 2019 May 1;177:68-76. doi: 10.1016/j.colsurfb.2019.01.050. Epub 2019 Jan 24. Colloids Surf B Biointerfaces. 2019. PMID: 30711761 Free article.
Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia.
Gómez-Seguí I, Cervera J, Such E, Martínez-Cuadrón D, Luna I, Ibáñez M, López-Pavía M, Gascón A, Roig M, Martínez J, Sanz J, Montesinos P, Martín-Aragonés G, Lorenzo I, Senent L, Barragán E, Cordón L, Sempere A, Sanz GF, Sanz MA. Gómez-Seguí I, et al. Among authors: cordon l. Ann Hematol. 2012 Jan;91(1):19-25. doi: 10.1007/s00277-011-1331-z. Epub 2011 Sep 21. Ann Hematol. 2012. PMID: 21935650
Significance of increased blastic-appearing cells in bone marrow following myeloablative unrelated cord blood transplantation in adult patients.
Montesinos P, Gascón A, Martínez-Cuadrón D, Senent ML, Cordón L, Sanz J, Sempere A, López-Pavía M, Rodríguez-Veiga R, Hurtado MJ, Gomis F, Martín G, Lorenzo I, Palau J, Planelles MD, Larrea L, Carpio N, Pérez-Sirvent M, Sanz MA, Sanz GF. Montesinos P, et al. Among authors: cordon l. Biol Blood Marrow Transplant. 2012 Mar;18(3):388-95. doi: 10.1016/j.bbmt.2011.11.008. Epub 2011 Nov 9. Biol Blood Marrow Transplant. 2012. PMID: 22079468 Free article.
Human Mesenchymal Stem Cells Growth and Osteogenic Differentiation on Piezoelectric Poly(vinylidene fluoride) Microsphere Substrates.
Sobreiro-Almeida R, Tamaño-Machiavello MN, Carvalho EO, Cordón L, Doria S, Senent L, Correia DM, Ribeiro C, Lanceros-Méndez S, Sabater I Serra R, Gomez Ribelles JL, Sempere A. Sobreiro-Almeida R, et al. Among authors: cordon l. Int J Mol Sci. 2017 Nov 11;18(11):2391. doi: 10.3390/ijms18112391. Int J Mol Sci. 2017. PMID: 29137121 Free PMC article.
A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Martínez-Cuadrón D, Boluda B, Martínez P, Bergua J, Rodríguez-Veiga R, Esteve J, Vives S, Serrano J, Vidriales B, Salamero O, Cordón L, Sempere A, Jiménez-Ubieto A, Prieto-Delgado J, Díaz-Beyá M, Garrido A, Benavente C, Pérez-Simón JA, Moscardó F, Sanz MA, Montesinos P; CETLAM and PETHEMA groups. Martínez-Cuadrón D, et al. Among authors: cordon l. Ann Hematol. 2018 May;97(5):763-772. doi: 10.1007/s00277-018-3229-5. Epub 2018 Feb 2. Ann Hematol. 2018. PMID: 29392425 Clinical Trial.
Correction to: A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia.
Martínez-Cuadrón D, Boluda B, Martínez P, Bergua J, Rodríguez-Veiga R, Esteve J, Vives S, Serrano J, Vidriales B, Salamero O, Cordón L, Sempere A, Jiménez-Ubieto A, Prieto-Delgado J, Díaz-Beyá M, Garrido A, Benavente C, Pérez-Simón JA, Moscardó F, Sanz MA, Montesinos P; CETLAM and PETHEMA groups. Martínez-Cuadrón D, et al. Among authors: cordon l. Ann Hematol. 2018 May;97(5):923. doi: 10.1007/s00277-018-3277-x. Ann Hematol. 2018. PMID: 29473097 Free article.
Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia.
Paiva B, Vidriales MB, Sempere A, Tarín F, Colado E, Benavente C, Cedena MT, Sánchez J, Caballero-Velazquez T, Cordón L, Garces JJ, Simoes C, Martínez-Cuadrón D, Bernal T, Botella C, Grille S, Serrano J, Rodríguez-Medina C, Algarra L, Alonso-Domínguez JM, Amigo ML, Barrios M, García-Boyero R, Colorado M, Pérez-Oteyza J, Pérez-Encinas M, Costilla-Barriga L, Sayas MJ, Pérez O, González-Díaz M, Pérez-Simón JA, Martínez-López J, Sossa C, Orfao A, San Miguel JF, Sanz MÁ, Montesinos P; PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group. Paiva B, et al. Among authors: cordon l. Leukemia. 2021 Aug;35(8):2358-2370. doi: 10.1038/s41375-021-01126-3. Epub 2021 Feb 1. Leukemia. 2021. PMID: 33526859
40 results